There is no current commercial partnership with Edwards Lifesciences (this is my pick for partner down the track) as this would need to be disclosed to market but its common knowledge that after the human trials start this month its open slather on the market for a race to finalise partnership deal. (expect any time in 2020/21/22)
It would be lax to assume all major players in cardiac healthcare have not been consulted in some form. we are on the map. Wayne must remain. admedus tavr will change the world.
There is no current commercial partnership with Edwards...
Add AVR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$21.15 |
Change
-0.350(1.63%) |
Mkt cap ! $413.0M | |||
| Open | High | Low | Value | Volume |
| $21.25 | $21.25 | $21.15 | $53.18K | 2.509K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 493 | $21.10 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $21.19 | 105 | 2 |
View Market Depth
| Last trade - 10.28am 07/05/2024 (20 minute delay) ? |
| AVR (ASX) Chart |